Company / Working Capital
Crinetics Pharmaceuticals, Inc. Working Capital History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$963.3M
FY2025
5-year range
$317.5M / $1.3B
FY2021-FY2025
Trend
-26.8%
vs FY2024
Sector context
#40 of 213
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s working capital of $963M is higher than 81% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 9 years, ranging from $14M in FY2017 to $1.3B in FY2024.
Based on SEC 10-K filings.
$963M in FY2025 with a 5-year CAGR of +42.0%. Top quartile in the Health Care sector.
Improved from $530M to $963M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +44.8%
- 5-Year CAGR
- +42.0%
- 10-Year CAGR
- -
Sector benchmark
+3.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +42.0%, indicating consistent growth.
- In FY2025, working capital decreased 26.8% year-over-year.
- Ranks #40 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $963.3M | -26.8% |
| FY2024 | $1.3B | +148.1% |
| FY2023 | $530.2M | +67.0% |
| FY2022 | $317.5M | -3.4% |
| FY2021 | $328.7M | +96.8% |
| FY2020 | $167.0M | +45.2% |
| FY2019 | $115.0M | -27.6% |
| FY2018 | $158.8M | +1012.7% |
| FY2017 | $14.3M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026